Evidence map›Paper›PMID 36140350›Full record

ArticleBiomedicines2022

Immunomodulatory Factor TIM3 of Cytolytic Active Genes Affected the Survival and Prognosis of Lung Adenocarcinoma Patients by Multi-Omics Analysis.

Liusheng Wu, Yanfeng Zhong, Dingwang Wu, Pengcheng Xu, Xin Ruan, Jun Yan, Jixian Liu, Xiaoqiang Li

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 117 papers.

0numbers the graph read from it
0cells of the map it votes in
117citing papers in PubMed
14.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

117 citing papers in PubMed, 103 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

57 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Liusheng WuPeking University Shenzhen Hospital, Clinical College of Anhui Medical University, Tsinghua university, Shenzhen 518036, China.ORCID 0000-0001-9580-2257
Yanfeng ZhongThoracic Surgery, Peking University Shenzhen Hospital, Shenzhen 518036, China.
Dingwang WuThoracic Surgery, Peking University Shenzhen Hospital, Shenzhen 518036, China.
Pengcheng XuThoracic Surgery, Peking University Shenzhen Hospital, Shenzhen 518036, China.
Xin RuanThoracic Surgery, Peking University Shenzhen Hospital, Shenzhen 518036, China.
Jun YanPeking University Shenzhen Hospital, Clinical College of Anhui Medical University, Tsinghua university, Shenzhen 518036, China.
Jixian LiuThoracic Surgery, Peking University Shenzhen Hospital, Shenzhen 518036, China.
Xiaoqiang LiThoracic Surgery, Peking University Shenzhen Hospital, Shenzhen 518036, China.ORCID 0000-0002-9692-1458
Peking University Shenzhen Hospital · CNAnhui Medical University · CN

Funding

Scientific Research Project of Education Department of Anhui Province YJS20210324
6 · The paper itself

Abstract

[

Indexed as

cytolytic activitydrug sensitivityimmune checkpointimmunoregulatory factorlung adenocarcinomamulti-omics study

Identifiers

PMID36140350
PMCPMC9496572
OpenAlexW4295537207

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.